ResearcherYangpu Hospital of Tongji UniversityActive in the last 2 years

Xi Wu

ORCID-verified (high confidence)As of 10 November 2026

Matched on ORCID iD 0000-0003-0429-8556; OpenAlex author ID A5080897588.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Collaborators: 3

Papers, trials and grants by year

2026: 2 papers

Papers 2

Ginsenoside Rb1 From the Functional Food Panax ginseng Suppresses Pancreatic Cancer Progression via Macrophage Reprogramming Through the PI3K-AKT Pathway. Last author DOI 10.1002/fsn3.72468 ↗
A single-cell and machine learning framework identifies CAFs-associated signatures linking stromal heterogeneity to immune regulation in pancreatic cancer. Co-author DOI 10.21037/jgo-2026-0297 ↗

Closest collaborators

The 3 strongest of 3 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

B Li · 1 shared paper, 2026
- Paper A single-cell and machine learning framework identifies CAFs-associated signatures linking stromal heterogeneity to imm… DOI 10.21037/jgo-2026-0297 ↗
F L Xing · 1 shared paper, 2026
- Paper A single-cell and machine learning framework identifies CAFs-associated signatures linking stromal heterogeneity to imm… DOI 10.21037/jgo-2026-0297 ↗
Changsheng Dong · 1 shared paper, 2026
- Paper Ginsenoside Rb1 From the Functional Food Panax ginseng Suppresses Pancreatic Cancer Progression via Macrophage Reprogra… DOI 10.1002/fsn3.72468 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.